Table 3.
Surgical procedure and pathology of lesions in the two groups
| Variables | Group M | GroupB | P |
|---|---|---|---|
| Conversion rate (%) | 0 | 0 | |
| Technical success of wedge resection | 90.3% | 85.3% | 0.538 |
| Surgical procedure | 0.103 | ||
| Wedge resection | 28 | 29 | |
| Segmentectomy/lobectomy | 3 | 5 | |
| Duration for surgical wedge resection (min) | 16.9 ± 3.7 | 22.6 ± 3.3 | 0.001 |
| Pathology | 0.452 | ||
| Leiomyoma | 2 (6.5) | 0 (0.0) | |
| Inflammatory pseudotumor | 2 (6.5) | 1 (3.0) | |
| Hamartoma | 2 (6.5) | 0 (0.0) | |
| Atypical hyperplasia | 1 (3.2) | 2 (6.1) | |
| Adenocarcinoma in situ | 13 (41.8) | 15 (45.4) | |
| Minimally invasive adenocarcinoma | 7 (22.6) | 9 (27.3) | |
| Invasive adenocarcinoma | 4 (12.9) | 7 (21.2) |